Elanco Short Term Investments vs Short Term Debt Analysis
ELAN Stock | USD 17.19 0.21 1.24% |
Elanco Animal financial indicator trend analysis is much more than just examining Elanco Animal Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Elanco Animal Health is a good investment. Please check the relationship between Elanco Animal Short Term Investments and its Short Term Debt accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Short Term Investments vs Short Term Debt
Short Term Investments vs Short Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Elanco Animal Health Short Term Investments account and Short Term Debt. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Elanco Animal's Short Term Investments and Short Term Debt is 0.16. Overlapping area represents the amount of variation of Short Term Investments that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Elanco Animal Health, assuming nothing else is changed. The correlation between historical values of Elanco Animal's Short Term Investments and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Investments of Elanco Animal Health are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Short Term Investments i.e., Elanco Animal's Short Term Investments and Short Term Debt go up and down completely randomly.
Correlation Coefficient | 0.16 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Short Term Investments
Short Term Investments is an item under the current assets section of Elanco Animal balance sheet. It contains any investments Elanco Animal Health undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Elanco Animal Health can easily liquidate in the marketplace.Short Term Debt
Most indicators from Elanco Animal's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Elanco Animal Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Elanco Animal reported last year Issuance Of Capital Stock of (100,000). As of the 19th of May 2024, Enterprise Value Over EBITDA is likely to grow to 23.56, while Tax Provision is likely to drop (13.7 M).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 2.6B | 2.5B | 2.5B | 2.0B | Total Revenue | 4.8B | 4.4B | 4.4B | 3.9B |
Elanco Animal fundamental ratios Correlations
Click cells to compare fundamentals
Elanco Animal Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Elanco Animal fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 370.3M | 441.4M | 487.2M | 488.3M | 492.3M | 447.6M | |
Total Assets | 9.0B | 17.7B | 16.5B | 15.5B | 14.4B | 13.6B | |
Other Current Liab | 455.4M | 872.2M | 746M | 924M | 409M | 631.8M | |
Total Current Liabilities | 818.5M | 2.1B | 1.6B | 1.7B | 1.2B | 1.3B | |
Total Stockholder Equity | 5.5B | 8.5B | 7.5B | 7.3B | 6.2B | 7.6B | |
Other Liab | 228.2M | 1.3B | 1.2B | 941M | 1.1B | 780.6M | |
Net Tangible Assets | 74.5M | (4.1B) | (4.3B) | (3.5B) | (3.2B) | (3.0B) | |
Property Plant And Equipment Net | 955.3M | 1.3B | 1.1B | 999M | 1.0B | 1.1B | |
Net Debt | 2.0B | 5.6B | 5.7B | 5.5B | 5.4B | 3.5B | |
Retained Earnings | 84.3M | (477.2M) | (949M) | (1.1B) | (2.3B) | (2.2B) | |
Accounts Payable | 222.6M | 501M | 418M | 390M | 270M | 335.3M | |
Cash | 334M | 494.7M | 638M | 345M | 352M | 442.8M | |
Non Current Assets Total | 6.6B | 14.3B | 13.2B | 12.2B | 11.0B | 10.5B | |
Non Currrent Assets Other | 185M | 347.8M | 387M | 378M | 341M | 300.8M | |
Other Assets | 78.9M | 127.3M | 183M | 193M | 173.7M | 123.4M | |
Cash And Short Term Investments | 334M | 494.7M | 638M | 345M | 352M | 442.8M | |
Net Receivables | 889.9M | 1.1B | 1.0B | 1.0B | 1.0B | 955.4M | |
Good Will | 3.0B | 6.2B | 6.2B | 6.0B | 5.1B | 4.8B | |
Liabilities And Stockholders Equity | 9.0B | 17.7B | 16.5B | 15.5B | 14.4B | 13.6B | |
Non Current Liabilities Total | 2.6B | 7.1B | 7.3B | 6.5B | 6.9B | 4.7B | |
Inventory | 1.1B | 1.6B | 1.4B | 1.5B | 1.7B | 1.4B | |
Other Current Assets | 87.4M | 256.3M | 237M | 394M | 310M | 236.1M | |
Other Stockholder Equity | 5.6B | 8.7B | 8.7B | 8.7B | 8.8B | 8.4B | |
Total Liab | 3.4B | 9.2B | 8.9B | 8.2B | 8.1B | 6.0B | |
Property Plant And Equipment Gross | 955.3M | 1.3B | 2.1B | 1.7B | 1.8B | 1.4B | |
Total Current Assets | 2.4B | 3.4B | 3.3B | 3.3B | 3.4B | 3.1B | |
Accumulated Other Comprehensive Income | (173.7M) | 303M | (209M) | (392M) | (266M) | (279.3M) | |
Non Current Liabilities Other | 106.6M | 322.1M | 261M | 229M | 411M | 232.2M | |
Intangible Assets | 2.5B | 6.4B | 5.6B | 4.8B | 4.5B | 4.3B | |
Property Plant Equipment | 1.0B | 1.3B | 1.2B | 999M | 1.1B | 1.1B | |
Net Invested Capital | 7.9B | 14.6B | 13.9B | 13.1B | 12.0B | 12.1B | |
Net Working Capital | 1.6B | 1.3B | 1.6B | 1.6B | 2.2B | 1.8B | |
Short Long Term Debt Total | 2.4B | 6.1B | 6.3B | 5.8B | 5.8B | 5.3B | |
Current Deferred Revenue | 116M | 148.6M | 185M | 524M | 602.6M | 632.7M | |
Long Term Debt | 2.3B | 5.6B | 6.0B | 5.4B | 5.7B | 5.1B | |
Retained Earnings Total Equity | 84.3M | (477.2M) | (949M) | (1.1B) | (951.3M) | (903.7M) | |
Capital Surpluse | 5.6B | 8.7B | 8.7B | 8.7B | 10.0B | 8.2B | |
Short Long Term Debt | 24.5M | 554.5M | 294M | 388M | 38M | 36.1M | |
Short Term Debt | 24.5M | 554.5M | 294M | 388M | 38M | 36.1M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Elanco Animal Health information on this page should be used as a complementary analysis to other Elanco Animal's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Elanco Stock analysis
When running Elanco Animal's price analysis, check to measure Elanco Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elanco Animal is operating at the current time. Most of Elanco Animal's value examination focuses on studying past and present price action to predict the probability of Elanco Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elanco Animal's price. Additionally, you may evaluate how the addition of Elanco Animal to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Elanco Animal's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elanco Animal. If investors know Elanco will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elanco Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.71) | Earnings Share (2.65) | Revenue Per Share 8.857 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0103 |
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.